The p53 paralogues p73, p63 and their respective truncated isoforms have been shown to be critical regulators of developmental and differentiation processes. Indeed, both p73-and p63-deficient mice exhibit severe developmental defects. Here, we show that S100A2 gene, whose transcript and protein are induced during keratinocyte differentiation of HaCaT cells, is a direct transcriptional target of p73b and DNp63a and is required for proper keratinocyte differentiation. Transactivation assays reveal that p73b and DNp63a exert opposite transcriptional effects on S100A2 gene. While DNp63a is found in vivo onto S100A2 regulatory regions predominantly in proliferating cells, p73b is recruited in differentiating cells. Silencing of p73 impairs the induction of S100A2 during the differentiation of HaCaT cells. Moreover, silencing of p73 or S100A2 impairs the proper expression of keratinocyte differentiation markers. Of note, p53 family members do not trigger S100A2 gene expression in response to apoptotic doses of cisplatin and doxorubicin.
Introduction
The recently established p53 family is heavily involved in the transcriptional control of many biological processes ranging from growth arrest and apoptosis to development and differentiation (Blandino and Dobbelstein, 2004) . Unlike p53-deficient mice, which grow quite normally but undergo spontaneous tumor development, mainly sarcomas and lymphomas, p73 and p63 knockout mice exhibit severe developmental defects (Mills et al., 1999; Yang et al., 1999 Yang et al., , 2000 .
p73 and p63 share a remarkable homology in DNA sequence as well as in protein structure with p53 (Kaghad et al., 1997; Yang et al., 1998 Yang et al., , 2002 . Like p53, whose isoforms have been recently identified (Bourdon et al., 2005) , p73 and p63 are subjected to alternative splicing, giving rise to a family of proteins, whose individual function has not been elucidated yet (De Laurenzi et al., 1998 Zaika et al., 1999; Pozniak et al., 2000) . The ectopic expression of p73 and p63 in p53À/À and p53 þ / þ cells causes, similarly to p53, growth arrest, apoptosis and differentiation (Jost et al., 1997; Kaghad et al., 1997; Yang et al., 1998; De Laurenzi et al., 2000; Fontemaggi et al., 2002; Strano et al., 2005) . These effects are achieved mainly through the activation of a plethora of specific target genes. Several reports have shown that p73 and p63 bind to p53-binding sites, in vitro and in vivo, and consequently activate p53 target genes (Jost et al., 1997; Kaghad et al., 1997) . Thus, transcriptional activation and repression of specific sets of target genes or the recruitment of specific co-activators and co-repressors might explain the major differences between p53 family members when their respective gene targeting phenotypes are compared. We have previously shown through microarray analysis that inducible expression of p53 or p73a promotes the transcriptional activation or repression of common as well as quite distinct patterns of direct target genes (Fontemaggi et al., 2002) . Among them we found that S100A2 gene was induced by p73a, but not by p53. The gene product of S100A2 is a member of the calciumbinding S100 family of proteins and was identified in a screen for tumor suppressor genes by subtractive hybridization between normal mammary epithelial cells and breast tumor cells (Vellucci et al., 1995) . S100 proteins are characterized by common structural motifs including two EF hands (helix-loop-helix calciumbinding domain) that are separated by a hinge region and flanked by amino-and carboxy-terminal domains. At least 10 of S100 proteins are clustered in the epidermal differentiation complex (EDC) located on human chromosomal band 1q21 (Mischke et al., 1996; Eckert et al., 2004) . The EDC also contains the genes encoding loricrin, involucrin, filaggrin, trichohyalin and several small proline-rich region proteins known to play important structural roles in keratinocyte terminal differentiation, including keratin filament reorganization, chromatin condensation and cornified envelope formation (Dale et al., 1997; Steinert and Marekov, 1997) . S100 proteins appear to influence cell shape and motility via calcium-dependent interactions with cytoskeletal proteins and modulation of protein kinase activity (Heierhorst et al., 1996; Donato, 2003) , suggesting that they may mediate at least some of the protean effects of calcium on epithelial differentiation. Recent report showed that some S100 proteins interact with the C-terminal domain of p53 and disrupt its tetramerization leading to interference in the cellular localization of p53 (Fernandez-Fernandez et al., 2005) .
Here, we show that S100A2 gene is a direct transcriptional target of DNp63a and p73b during keratinocyte differentiation. Unlike DNp63a, which is predominantly found on the regulatory regions of S100A2 in proliferating cells, p73b is recruited to S100A2 during keratinocyte differentiation of HaCaT cells. We also found that DNp63a and p73b exert opposite transcriptional effects on S100A2 gene. Indeed, DNp63a functions as a transcriptional repressor, whereas p73b promotes the transcriptional activity of S100A2 gene. Silencing of S100A2 impairs proper differentiation, indicating its active participation to the differentiation process. The latter is neither activated nor recruited by p73 during cisplatin-induced apoptosis of diverse cell lines. Altogether, our data contribute to identify S100A2 gene as a direct target of p53 family members during keratinocyte differentiation.
Results

S100A2 expression is induced during keratinocyte differentiation
To search for target genes specifically activated or repressed by p73 and not by wt-p53, we have previously performed a DNA microarray analysis (Fontemaggi et al., 2002 ) using a cell line whose ectopic inducible expression of either p73a or p53 was under the control of ponasterone A. S100A2 was found to be a transcriptional target of p73 but not of p53 (Fontemaggi et al., 2002) . Here we show that S100A2 transcript and protein are induced during keratinocyte differentiation of HaCaT cells (Figure 1a and d). It has previously been reported that the expression of p53 family members is modulated during keratinocyte differentiation. In particular, DNp63, which is the most abundant p63 isoform in HaCaT cells (Figure 1c ), is downregulated, and p73 is upregulated (De Laurenzi et al., 2000; Bamberger et al., 2002) . As shown in Figure 1a -d, we found that the p53 family members and differentiation E Lapi et al induction of S100A2 during keratinocyte differentiation of HaCaT cells pairs with the downregulation of DNp63a and the upregulation of p73b. The latter is the only p73 isoform present in HaCaT cells, as determined by RT-polymerase chain reaction (PCR) using primers that discriminate between the different p73 isoforms (Figure 1a and data not shown). The analysis of p21 waf1 , involved in the exit from cell cycle, and two differentiation markers (involucrin and keratin 10) confirmed the proper differentiated status of HaCaT cells (Figure 1a and d) . The modulation of both S100A2 and p53 family members' expression was also found during differentiation of primary human epidermal keratinocytes (HEKs) (data not shown).
S100A2 is a direct transcriptional target of p73b and DNp63a Next, we aimed to investigate whether S100A2 was a direct transcriptional target of p53 family members during keratinocyte differentiation. We have previously found that the second intron of human S100A2 gene contains two inverted/repeated p53/p63/p73 consensus sites (Fontemaggi et al., 2002) (Figure 2a ). It has also been reported that S100A2 promoter encloses a p53/ p63/p73 consensus site, which has been shown to be transcriptionally activated by wt-p53 (Tan et al., 1999 and data not shown) (Figure 2a) . To assess the ability of p53 family members to directly bind in vitro the p53/ p63/p73-binding site of S100A2 promoter, we performed an electrophoretic mobility shift assay (EMSA). To this end, a phospholabeled oligonucleotide encompassing the p53/p63/p73 consensus of S100A2 promoter was incubated with an in vitro translated p73b or DNp63a or TAp63a protein, respectively. As shown in Figure 2b p73b, DNp63a and TAp63a were able to bind the consensus of S100A2 promoter. The addition of anti-p73 or anti-p63 antibodies to the reaction mixture decreased (lanes 6, 10 and 15) or weakly supershifted (lane 15) the binding, thus confirming the specificity of these DNA/protein complexes (Figure 2b ).
To further investigate whether the above-mentioned binding sites contained in the regulatory regions of S100A2 gene confer p73/p63-dependent transcriptional activity, we performed transactivation assays. To this end, the consensus site of the promoter and the two consensus enclosed in the second intron of S100A2 gene were individually cloned into a TK-LUC reporter construct. As shown in Figure 2c , ectopic expression of p73b promotes the transcriptional activation of S100A2 regulatory regions, while DNp63a induces a strong transcriptional repression. Unlike DNp63a and p73b, p63a is unable to transcriptionally modulate S100A2 gene, at least under our experimental conditions. Altogether, these results indicate that p73b and DNp63a exert opposite transcriptional effects onto S100A2 regulatory regions.
In vivo recruitment of p73b and DNp63a onto the regulatory regions of S100A2 gene To verify whether the S100A2 upregulation during keratinocyte differentiation depends on the transcriptional activity of p53 family members, we analysed by chromatin immunoprecipitation (ChIP) the in vivo binding pattern of p73b and DNp63a onto S100A2 regulatory regions. To this end, crosslinked chromatin derived from equivalent numbers of proliferating (P) and terminally differentiated (TD) HaCaT cells was immunoprecipitated by using antibodies against p73 and p63 (TAp63 and DNp63). We found that the amount of p73b bound to the regulatory regions of S100A2 is mainly increased at the level of the second intron in differentiated cells (Figure 3a) . Conversely, p63 is recruited onto S100A2 promoter mainly in proliferating cells and its binding is reduced upon differentiation ( Figure 3a ). It is reasonable to believe that the p63 bound to S100A2 promoter is predominantly DNp63a, as we observed ( Figure 1a ) and it is reported (Bamberger et al. 2002) that DNp63a is the most abundant p63 isoform present in human keratinocytes. p63 was not recruited onto the second intron of S100A2 gene, suggesting that the promoter occupancy might be sufficient to exert its transcriptional repression (Figure 3a) . No specific occupancy by p73b and DNp63 was found on the thymidine kinase (TK) promoter (Figure 3a ), which does not contain any p73/p63-binding site. The induction of S100A2 transcript during keratinocyte differentiation might result from the combinatorial activity of DNp63 and p73b. In particular, while DNp63 downregulation releases its repressive activity, p73b upregulation might be involved in the full transcriptional activation of S100A2 during differentiation.
We next verified whether the transcriptional activation of S100A2 during the keratinocyte differentiation Figure 2 DNp63a and p73b exert opposite transcriptional effects on S100A2 gene. (a) Schematic representation of the S100A2 gene. Arrows indicate p53/p63/p73 consensus sites of S100A2 promoter and second intron; positions are relative to the transcription start site. (b) Gel shift assay was performed using a probe resembling the p53/p63/p73 consensus of S100A2 promoter. p73b, DNp63 and TAp63 bind in vitro to the p53/p63/p73 consensus sites of S100A2 promoter (lanes 3, 7 and 12). The binding was competed with a 200-fold molar excess of unlabeled double-stranded probe (lanes 4, 8 and 13), but not with a 1000-fold molar excess of an unrelated oligonucleotide (lanes 5, 9 and 14). The addition of anti-p73 or anti-p63 antibodies to the reaction mixture decreased the amount of the binding (lanes 6, 10, and 15). (c-e) H1299 cells were transiently transfected with plasmids encoding p73b (c) or DNp63a (d) or TAp63a (e) (1 mg/60-mm dish) together with constructs carrying the luciferase reporter gene driven by S100A2 promoter or S100A2 second intron-binding site 1 (Intron 2-BS1) or S100A2 second intron-binding site 2 (Intron 2-BS2) (500 ng/60-mm dish). The total amount of transfected DNA in each dish was kept constant by the addition of empty vector. An equal amount of CMV-bgal was added to each transfection. Cell extracts were prepared 36 h later. Luciferase activity was determined relatively to total proteins and b-gal activity. We found an increase of H4 histone acetylation at 12 h onto the second intron of S100A2 gene (Figure 3b ). This correlates well with both S100A2 mRNA induction ( Figure 1b ) and the in vivo recruitment of p73 onto the S100A2 regulatory regions. No difference in the amount of H4 histone acetylation was found between proliferating and differentiating cells on S100A2 promoter ( Figure 3b ); this could be because of the significant basal expression level of S100A2 in proliferating cells (Figure 1a and b) . Altogether, these results indicate that the p73 consensus sequences present on S100A2 second Silencing of p73 expression impairs S100A2 upregulation during keratinocyte differentiation To further define the contribution of p73 to the induction of S100A2 expression during keratinocyte differentiation, we knocked-down p73 expression through RNA interference. Two different experimental approaches were used. First, HaCaT cells were transfected either with p73-specific small interfering RNAs (siRNAs) or unrelated siRNAs along with a vector encoding a green fluorescent protein (GFP) (Figure 4b and c), and the expression of S100A2 protein was evaluated by immunofluorescence. In agreement with previous findings, S100A2 protein was predominantly localized in the nuclei even at 12 h of differentiation ( Figure 4b ). We found that S100A2 expression in the GFP-positive/p73siRNAs-transfected cells (right panels, arrow) was clearly diminished when compared with that of the surrounding GFP-negative/untransfected cells.
The specificity of such effect was given by the observation that no modulation of S100A2 expression was seen in the cells transfected with the unrelated siRNAs (Figure 4b , left panels and Figure 4c ). In the second approach, HaCaT cells were stably transfected with either a retroviral vector p73pRetroSuper (p73pRS), expressing siRNAs against p73, or with a control vector lacZpRS. As shown in Figure 4d , the induction of both p73 and S100A2 mRNAs in differentiating HaCaT cells transfected with p73pRS vector was reduced when compared with that of lacZpRS-transfected cells. This effect pairs a reduced induction of keratin 10 and involucrin, two well-known markers of keratinocyte differentiation (Figure 4d ). These findings indicate that p73 expression is required for S100A2 upregulation during keratinocyte differentiation and for the proper expression of differentiation markers.
Silencing of S100A2 impairs keratinocyte differentiation To define whether S100A2 contributes to keratinocyte differentiation, HaCaT cells were stably transfected with either a retroviral vector S100A2pRS or with a lacZpRS. As shown in Figure 5b , the induction of S100A2 mRNA in differentiating HaCaT cells transfected with S100A2pRS vector was impaired when compared with that of lacZpRS-transfected cells. This leads to a reduced induction of keratin 10 and involucrin (Figure 5c and d) . Altogether, our findings indicate that S100A2 participates actively in proper keratinocyte differentiation.
S100A2 gene is not induced in response to DNA damage A growing number of evidences have shown that p53 family members are transcription factors heavily involved in the apoptosis induced by common anticancer treatments. This effect occurs mainly through the transcriptional activation of a plethora of target genes that were originally identified within p53-mediated apoptotic processes. To assess whether S100A2 is a target of p53 family members not only during keratinocyte differentiation but also upon DNA damageinduced apoptosis, we treated HaCaT cells with different amounts of cisplatin at different time points. This treatment provokes apoptotic cell death as assessed by PARP fragmentation (Figure 6a ) and subG1 fraction analyses (Figure 6b ). The extent of the CDDP-induced apoptosis is dose dependent (Figure 6a and b) . The protein analysis of p53 family members reveals that while p73 is accumulated, DNp63 expression is strongly reduced (Figure 6a ). As expected for a mutant p53 protein, no modification of its expression was found in response to cisplatin (Figure 6a ). We found that while p73-mediated growth arrest and apoptotic target genes p21 waf1 , bax, p53AIP1, pig-3 were induced upon cisplatin treatment, S100A2 mRNA and protein, in agreement with previously reported findings (Dazard et al., 2003) , were downregulated (Figure 6a-c) . Similar findings were obtained upon treatment of HaCaT cells with doxorubicin (data not shown). This effect does not seem to be related to p53 family members activities. Upregulation of S100A2 was also not observed during p73-mediated apoptosis of HCT116 (3) cells in response to DNA damage (data not shown) (Costanzo et al., 2002; Mantovani et al., 2004; Strano et al., 2005) .
By ChIP analysis, we found that p73 is recruited on the first intron of its proapoptotic target gene p53AIP1 only in response to cisplatin (Figure 6d) . Conversely, the binding of p73 to S100A2 promoter was not modulated upon cisplatin treatment (Figure 6d) .
Altogether, these findings highlight S100A2 as a transcriptional target that might be selectively activated by p53 family members during differentiation. 
Discussion
Unlike p53-deficient mice that grow normally but undergo spontaneous tumor development, mainly sarcoma and lymphomas, p73 and p63 knockout mice exhibit severe developmental and differentiation defects (Mills et al., 1999; Yang et al., 1999 Yang et al., , 2000 . Different p73 and p63 isoforms, either derived from alternative splicing or by a cryptic promoter located in the third intron of the genes, are present in normal and tumor cells. Altogether, they give rise to a network of proteins whose fine-tuning dictates biological activities ranging from development and differentiation to growth arrest and apoptosis. Although the alternative splicing products lack different portions of the C-terminus, those originating by an intrinsic promoter are N-terminal truncated and have been shown to counteract p53-and p73-induced antitumoral effects (Blandino and Dobbelstein, 2004) . As a consequence, it is reasonable to assume that the major role of p73 and p63, during differentiation/development processes, is the transcriptional activation or repression of specific sets of genes. Here, we show that S100A2 gene is an in vivo direct transcriptional target of p53 family members during keratinocyte differentiation of HaCaT cells. Interestingly, p73b and DNp63a play opposite functions in regulating S100A2 gene at the transcriptional level. Indeed, we found that whereas p73b is a transcriptional activator of S100A2 gene, DNp63a functions as a transcriptional repressor. Further support to the opposite transcriptional regulation of S100A2 gene is provided by the differential in vivo recruitment during differentiation of p73b and DNp63a onto the regulatory regions on S100A2 gene. DNp63a is found predominantly in proliferating cells, whereas p73b is recruited in differentiating cells. Altogether, our findings might contribute to define a regulatory network of p53 family members existing at the cross-road between proliferation and differentiation that controls the activation or repression of selected target genes at the transcriptional level. Furthermore, our findings identify S100A2 as one of those genes whose activation contributes to switch proliferation into differentiation. The transcript of S100A2 was previously shown to be positively modulated by exogenous expression of DNp63a (Hibi et al., 2003) . This opposite finding might reflect different activities of DNp63a related either to the different cell context or to the specific biological activity in which the latter is recruited.
Target genes of p53 family members could be hypothetically divided, at least, in two large categories.
The first one includes genes that are activated by all the p53 family members and broadly involved in growth arrest, apoptosis and differentiation (el-Deiry et al., 1993; Attardi et al., 2000; Ihrie et al., 2005) . In such case, the cell context, the type of stimulus, the quantitative balance between the diverse p53 family members could be some of the key determinants in dictating the final biological output. The second class includes target genes that are selectively activated by each of the p53 family members, comprising p53, p73, p63 and their related isoforms, and mediate a specific biological activity. The findings that S100A2 gene is not triggered in response to different types and amounts of DNA damage in diverse cell contexts indicate that it might fall in this last category of genes.
Unbalanced proliferation and lack of proper differentiation are two hallmarks of many types of cancer cells. S100A2 gene was originally identified in a screen for tumor suppressor genes (Vellucci et al., 1995) . It has been shown that the levels of S100A2 inversely correlate with tumor progression in melanoma, breast and prostate cancer (Vellucci et al., 1995; Maelandsmo et al., 1997; Gupta et al., 2003) , thus indicating that it may play a role in suppressing tumor cell growth.
Here we provide evidence that might support a model of a cooperative activation of the tumor suppressor genes p73 and S100A2, whose spatially and temporally coordinated activities contribute to fulfill the requirements for completing the differentiation program. The proper execution of the latter can be considered a safeguard mechanism against cancer whose molecular details require additional evidence.
Materials and methods
Cell culture
Transformed human HaCaT keratinocytes were cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine serum (FBS); differentiation was induced by removal of growth factors and addition of 2 mM CaCl 2 . Human epithelial non-small-cell lung carcinoma (NSCLC) cell line H1299 was maintained in RPMI supplemented with 10% fetal calf serum (FCS).
Immunoblot analysis
Total cell lysates were prepared as previously described (Strano et al., 2000) . The following antibodies were used: anti-p73 monoclonal antibody (Ab4, Neomarker) at a 1:200 dilution; anti-S100A2 monoclonal antibody (Transduction Laboratories) at a 1:1000 dilution; anti-p63 monoclonal antibody (4A4, Santa Cruz) at a 1:500 dilution; anti-p53 monoclonal antibody (DO1) at a 1:40 dilution; anti-p21 polyclonal antibody (C19, Santa Cruz) at a 1:200 dilution; anti-bax polyclonal antibody (N20, Santa Cruz) at a 1:200 dilution; anti-involucrin monoclonal antibody (from Dr Costanzo) at a 1:200 dilution; anti-Hsp70 monoclonal antibody (StressGen) at a 1:1000 dilution; anti-PARP p85 fragment polyclonal antibody (Promega) at a 1:400 dilution; anti-tubulin (Sigma) at a 1:1000 dilution.
Indirect immunofluorescence
Proliferating and differentiating HaCaT cells were fixed and processed as already described . Cells were incubated with an anti-S100A2 monoclonal antibody (Transduction Laboratories) used at a 1:250 dilution for 2 h.
Plasmids
Three S100A2 regulatory regions (one located in the promoter and two in the second intron) enclosing p53 family consensus sequences were amplified by PCR and cloned in SalI/BamHI sites of TK-LUC reporter vector (Fontemaggi et al., 2001) using the following oligonucleotides: S100A2 promoter, sense CCG ACC CGT TGT CTC GGT TC, antisense CAA GGG GGA AGG CCC AGA GA; S100A2 second intron (binding site 1), sense GTG TTC AAA GCC TGA CAC CTA ACT T, antisense TGG ATC ATA GCT CAC TGT AAT CTC G; S100A2 second intron (binding site 2), sense AAG TAG CTG GGA CTA CAA GCG TAT G, antisense GGG ATA GAA AAG CCC AGC TAA GAT A. Oligonucleotides, derived from p73 and S100A2, enclosing the following target sequences, were ligated into pRetro-Super expression plasmids as described previously (Brummelkamp et al., 2002) : TAp73, CCA GAC AGC ACC TAC TTC G; S100A2, CCA CAG TGA GCA GGT GGA C.
Transfections and luciferase assays Transient transfections were performed using either the calcium phosphate precipitation method (BES) or the Lipofectamine Plus reagent (GIBCO-BRL). Transient reporter assays were performed as described (Strano et al., 2000) . Control plasmid (pCMVneo) was added to equally normalize the amount of transfected DNA for each transfection. RNA extraction and reverse transcriptase reaction RNAs were isolated and reverse transcribed as previously described (Fontemaggi et al., 2002) . PCR analyses were carried out by using oligonucleotides specific for the following genes: S100A2 ( Real-time RT-PCR PCR was performed on the cDNA samples using an ABI PRISM 7500 Sequence Detector (PE Applied Biosystems). Specific primers for TAp63 and DNp63 isoforms, with similar amplification efficiencies, were used (Signoretti et al., 2000) . The housekeeping glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene was used as endogenous control to standardize the amount of RNA in each reaction (Taqman GAPDH control reagents).
Formaldehyde crosslinking and ChIP
ChIP experiments were performed as previously described (Fontemaggi et al., 2002) . The following antibodies were used: a mixture of anti-p73 polyclonal antibodies (sc-7237 and sc-7238) (Santa Cruz); anti-p63 polyclonal antibody (sc-8343) (Santa Cruz); anti-acetyl-histone H4 (cat. n. 06-866, Upstate Biotechnology, Inc.). Enrichment in S100A2, p53AIP1 and TK sequences was evaluated by PCR. The following specific oligonucleotides were used: S100A2 promoter (sense 5 0 -GCT CAC TAT GTG GGG TGA GG, antisense 5 0 -CTG CGT GTC CCT TAA ACA CA); S100A2 second intron (sense 5 0 -CTC AAG CAA TCC TCC CAA GT, antisense 5 0 -CAG CAA TCC TCC CAC CTT TA); p53AIP1 first intron (sense 5 0 -TGG GTA GGA GGT GAT CTC ACC, antisense 5 0 -GAG CAG CAC AAA ATG GAC TGG G). Oligonucleotides specific for TK promoter (down 5 0 -GTG AAC TTC CCG GAG GCG CAA, up 5 0 -GCC CCT TTA AAC TTG GTG GGC) were used as negative control.
EMSA
The EMSA was performed as described in Fontemaggi et al. (2001) . Recombinant p73b or DNp63 or TAp63 proteins were produced from plasmids carrying the cDNAs under the control of T7 promoter using TnT Coupled Reticulocyte Lysate Systems (Promega), according to the manufacturer's protocol. For supershift analysis, anti-p73 (sc-7237 and sc-7238 from Santa Cruz) and anti-p63 (sc-8343 from Santa Cruz) polyclonal antibodies were used. A double-stranded oligonucleotide corresponding to the p53 family consensus of S100A2 promoter was used as probe.
siRNA studies HaCaT cells were transiently transfected using the Lipofectamine Plus Reagent (Invitrogen) according to the manufacturer's protocol with 2 mg of GFP-expressing vector, along with either 1 mg of the control siRNAs (unrelated oligo) or with sip73 RNAs. At 24 h after the transfection, the cells were induced to differentiate as described above. SiRNAs were purchased from DHARMACON Inc. Sequences are available upon request. Stable expression of siRNAs directed against LacZ, p73 and S100A2 was obtained by transfection of HaCaT cells with pRetroSuper-LacZ (negative control), pRetroSuper-p73 or pRetroSuper-S100A2 vectors followed by selection with 1 mg/ml puromycin. After 10 days of culture in puromycin supplemented medium, confluent cells were induced to differentiate as described above.
Cell cycle analysis
Cells for cell cycle analysis were prepared as described in Strano et al. (2005) and then analysed by cytofluorimetry with an Epics-XL analyser (Coulter, Corporation). Data were analysed with the Multicycle software (Phoenix Flow System).
